Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
A new hope for Amarin? Vascepa generic settlement leaves analysts split on patent appeal success
Fierce Pharma
Wed, 06/17/20 - 10:20 pm
Amarin
Vascepa
generics
Apotex
U.S. states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit
Reuters
Wed, 06/10/20 - 11:53 pm
price fixing
generics
drug pricing
FDA issues 69 new and revised draft product-specific guidances
RAPS.org
Wed, 06/3/20 - 11:31 pm
FDA
generics
FDA approves the first generic for Amarin's Vascepa — but is a launch imminent?
Endpoints
Fri, 05/22/20 - 11:03 am
FDA
Amarin
Vascepa
Hikma
generics
Bangladesh pharma claims to be first to launch generic remdesivir
BioPharma Dive
Thu, 05/21/20 - 11:08 pm
Bangladesh
Beximco
generics
remdesivir
Gilead Sciences
COVID-19
Generic drugmaker Akorn files for bankruptcy
Beckers Hospital Review
Thu, 05/21/20 - 10:22 am
Akorn
generics
bankruptcy
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report
Fierce Pharma
Mon, 05/18/20 - 10:56 pm
Teva Pharmaceutical
price fixing
generics
COVID-19
Sandoz
JNJ
Novartis
Taro Pharmaceuticals
What COVID-19 means for generics companies
Pharmaforum
Wed, 05/13/20 - 11:12 am
COVID-19
pandemic
generics
Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries
Fierce Pharma
Tue, 05/12/20 - 05:16 pm
Gilead Sciences
generics
drug manufacturing
COVID-19
remdesivir
COVID-19 restrictions send generic drug shipping costs through the roof: survey
Fierce Pharma
Sat, 05/2/20 - 11:21 pm
COVID-19
generics
biosimilars
drug manufacturing
FDA guides generic drugmakers on bioequivalence study disruptions amid COVID-19
RAPS.org
Wed, 04/29/20 - 10:50 pm
FDA
generics
bioequivalence studies
COVID-19
pandemic
Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Beckers Hospital Review
Thu, 04/16/20 - 11:07 am
Mylan
Robert Coury
Upjohn
generics
M&A
COVID-19
pandemic
FDA Offers Guidance for Generic Drug Developers of Hydroxychloroquine, Chloroquine
RAPS.org
Mon, 04/13/20 - 09:52 pm
FDA
COVID-19
hydroxychloroquine sulfate
chloroquine phosphate
generics
Blackstone backs Alnylam with up to $2B investment
BioPharma Dive
Mon, 04/13/20 - 09:50 pm
generics
Alnylam
Blackstone
RNAi
Former Novartis exec wants to repurpose generic drugs to fight Covid-19
Stat
Tue, 04/7/20 - 10:15 am
Axcella Health
WHO
Novartis
generics
drug repurposing
COVID-19
Novartis cancels $1B sale of generics after antitrust concerns forced delays
Endpoints
Thu, 04/2/20 - 10:49 am
Novartis
generics
Sandoz
antitrust
Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss
Fierce Pharma
Mon, 03/30/20 - 08:20 pm
Amarin
Vascepa
generics
patents
AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license
Stat
Sat, 03/21/20 - 12:05 am
AbbVie
Kaletra
generics
Israel
COVID-19
Drugmaker rethinks its decision to double price of a generic after Trump calls it a coronavirus lifesaver — reports
Endpoints
Fri, 03/20/20 - 10:46 am
Donald Trump
COVID-19
generics
Rising Pharmaceuticals
drug pricing
chloroquine phosphate
Coronavirus spurs India to restrict exports of 2 dozen drugs
Fierce Pharma
Tue, 03/3/20 - 10:59 am
generics
India
coronavirus
COVID-19
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »